Table 4.
Variables | HR | Univariate | p | HR | Multivariate | p |
---|---|---|---|---|---|---|
95% CI | 95% CI | |||||
Sex (female vs. male) | 1.010 | 0.669–1.524 | 0.964 | — | — | — |
Age (≤ 70 vs. > 70) | 1.808 | 1.188–2.753 | 0.006∗ | 1.995 | 1.228–3.243 | 0.005∗ |
TNM stage (stage I/II vs. stage III/IV) | 3.613 | 2.280–5.726 | <0.001∗ | 4.379 | 2.447–7.836 | <0.001∗ |
Lymphatic invasion (negative vs. positive) | 2.256 | 1.449–3.513 | <0.001∗ | 0.884 | 0.471–1.661 | 0.702 |
Venous invasion (negative vs. positive) | 2.376 | 1.505–3.751 | < 0.001∗ | 1.435 | 0.785–2.626 | 0.241 |
History of colon polyps (negative vs. positive) | 0.768 | 0.447–1.321 | 0.340 | — | — | — |
SNORA5C expression (low vs. high)# | 1.608 | 1.053–2.456 | 0.028∗ | 2.128 | 1.278–3.545 | 0.004∗ |
#Cutoff threshold of SNORA5C expression was median value in all patients in this cohort; ∗p < 0.05.